ResMed is a leader in CPAP machines and other medical devices that help millions breathe better.

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre ...

On Thursday, ResMed Inc (NYSE:RMD) reported first-quarter adjusted EPS of $2.20, up 34% year over year, beating the consensus of $2.04. The company reported sales of $1.224 billion, up 11%, beating ...

Sometimes one company's loss is another company's gain. In medtech, for example, Philips' recent recall on ventilators and sleep apnea devices could end up benefiting ResMed, a San Diego, CA-based ...

Jan 29 (Reuters) - Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for ‌its devices used to manage sleep apnea. The company ...

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...

For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of ...

San Diego, California-based ResMed has received FDA 510(k) clearance for its small, portable continuous positive airway pressure (CPAP) device, the AirMini. The announcement was made during the JP ...

As Philips stares down an international recall of more than 2 million of its CPAP and sleep apnea machines, the respiratory devicemaker ResMed is looking to pick up the slack—but the surge in demand ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

ResMed Chief Executive Mick Farrell usually delegates negotiations with suppliers to the San Diego company’s production executives. But amid continuing component shortages, Farrell has been on ...

Jan 30 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep ...